rs75495782

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032575.3(GLIS2):​c.1259C>T​(p.Pro420Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0017 in 1,547,636 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0084 ( 21 hom., cov: 34)
Exomes 𝑓: 0.00097 ( 19 hom. )

Consequence

GLIS2
NM_032575.3 missense

Scores

3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.19

Publications

5 publications found
Variant links:
Genes affected
GLIS2 (HGNC:29450): (GLIS family zinc finger 2) This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear transcription factor with five C2H2-type zinc finger domains. The protein encoded by this gene is widely expressed at low levels in the neural tube and peripheral nervous system and likely promotes neuronal differentiation. It is abundantly expressed in the kidney and may have a role in the regulation of kidney morphogenesis. p120 regulates the expression level of this protein and induces the cleavage of this protein's C-terminal zinc finger domain. This protein also promotes the nuclear translocation of p120. Mutations in this gene cause nephronophthisis (NPHP), an autosomal recessive kidney disease characterized by tubular basement membrane disruption, interstitial lymphohistiocytic cell infiltration, and development of cysts at the corticomedullary border of the kidneys.[provided by RefSeq, Jan 2010]
PAM16 (HGNC:29679): (presequence translocase associated motor 16) This gene encodes a mitochondrial protein involved in granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling. This protein also plays a role in the import of nuclear-encoded mitochondrial proteins into the mitochondrial matrix and may be important in reactive oxygen species (ROS) homeostasis. Mutations in this gene cause Megarbane-Dagher-Melike type spondylometaphyseal dysplasia, an early lethal skeletal dysplasia characterized by short stature, developmental delay and other skeletal abnormalities. [provided by RefSeq, May 2017]
PAM16 Gene-Disease associations (from GenCC):
  • autosomal recessive spondylometaphyseal dysplasia, Megarbane type
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025081336).
BP6
Variant 16-4337208-C-T is Benign according to our data. Variant chr16-4337208-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 220093.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00842 (1282/152332) while in subpopulation AFR AF = 0.0294 (1223/41570). AF 95% confidence interval is 0.028. There are 21 homozygotes in GnomAd4. There are 609 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 21 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLIS2NM_032575.3 linkc.1259C>T p.Pro420Leu missense_variant Exon 7 of 7 ENST00000433375.2 NP_115964.2 Q9BZE0
GLIS2NM_001318918.2 linkc.1259C>T p.Pro420Leu missense_variant Exon 8 of 8 NP_001305847.1 Q9BZE0B3KTH4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLIS2ENST00000433375.2 linkc.1259C>T p.Pro420Leu missense_variant Exon 7 of 7 1 NM_032575.3 ENSP00000395547.1 Q9BZE0
GLIS2ENST00000262366.7 linkc.1259C>T p.Pro420Leu missense_variant Exon 8 of 8 2 ENSP00000262366.3 Q9BZE0
ENSG00000262712ENST00000574705.1 linkn.611G>A non_coding_transcript_exon_variant Exon 1 of 1 6
PAM16ENST00000577031.5 linkc.291+3712G>A intron_variant Intron 4 of 4 4 ENSP00000459113.1 I3L1U7

Frequencies

GnomAD3 genomes
AF:
0.00842
AC:
1281
AN:
152214
Hom.:
21
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0295
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00176
AC:
258
AN:
146918
AF XY:
0.00149
show subpopulations
Gnomad AFR exome
AF:
0.0280
Gnomad AMR exome
AF:
0.00146
Gnomad ASJ exome
AF:
0.000120
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000162
Gnomad OTH exome
AF:
0.00188
GnomAD4 exome
AF:
0.000972
AC:
1356
AN:
1395304
Hom.:
19
Cov.:
35
AF XY:
0.000838
AC XY:
577
AN XY:
688390
show subpopulations
African (AFR)
AF:
0.0313
AC:
989
AN:
31592
American (AMR)
AF:
0.00185
AC:
66
AN:
35744
Ashkenazi Jewish (ASJ)
AF:
0.0000795
AC:
2
AN:
25170
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35764
South Asian (SAS)
AF:
0.0000379
AC:
3
AN:
79260
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45318
Middle Eastern (MID)
AF:
0.00109
AC:
6
AN:
5490
European-Non Finnish (NFE)
AF:
0.000153
AC:
165
AN:
1079040
Other (OTH)
AF:
0.00216
AC:
125
AN:
57926
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
99
199
298
398
497
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00842
AC:
1282
AN:
152332
Hom.:
21
Cov.:
34
AF XY:
0.00817
AC XY:
609
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.0294
AC:
1223
AN:
41570
American (AMR)
AF:
0.00229
AC:
35
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68020
Other (OTH)
AF:
0.00473
AC:
10
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
58
116
173
231
289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00153
Hom.:
6
Bravo
AF:
0.00965
ESP6500AA
AF:
0.0170
AC:
63
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00113
AC:
107
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 25, 2024
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jun 28, 2021
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephronophthisis Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephronophthisis 7 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.13
T;T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.15
FATHMM_MKL
Benign
0.40
N
MetaRNN
Benign
0.0025
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L;L
PhyloP100
1.2
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-1.2
N;N
REVEL
Benign
0.048
Sift
Benign
0.062
T;T
Sift4G
Uncertain
0.014
D;D
Polyphen
0.0
B;B
Vest4
0.16
MVP
0.068
MPC
0.29
ClinPred
0.012
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.078
gMVP
0.43
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75495782; hg19: chr16-4387209; API